Literature DB >> 15565344

Colonic neuroendocrine carcinoma in a child.

Omai Al Sasi1, Rajeev Sathiapalan, Ayman Rifai, Asthma Mahmoud Mohamed Tulbah, Ali Al-Mehaidib, Amani Kofide, Claes Hugosson.   

Abstract

A 10-year-old boy with congenital immunodeficiency (X-linked agammaglobulinaemia) presented with loss of appetite and weight, right-sided abdominal pain, diarrhoea and low-grade fever. Radiological investigations with barium follow-through, CT, PET and octreotide scans revealed a primary caecal/ascending proximal colonic mass with liver and bony metastases. Urine screen for 5HIAA was positive. Percutaneous liver biopsy confirmed the diagnosis of neuroendocrine carcinoma. The radiological work-up and the usefulness of various imaging modalities in the diagnosis of this rare paediatric tumour are discussed. The PET scan demonstrated the primary tumour and the metastatic locations more vividly than the octreotide scan, which is currently considered to be the most specific imaging modality for neuroendocrine masses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565344     DOI: 10.1007/s00247-004-1319-0

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  8 in total

1.  Functional imaging of malignant paragangliomas and carcinoid tumours.

Authors:  C Le Rest; J B Bomanji; D C Costa; C E Townsend; D Visvikis; P J Ell
Journal:  Eur J Nucl Med       Date:  2001-04

2.  Childhood carcinoid tumors: the St Jude Children's Research Hospital experience.

Authors:  S L Spunt; C B Pratt; B N Rao; M Pritchard; J J Jenkins; D A Hill; A M Cain; A S Pappo
Journal:  J Pediatr Surg       Date:  2000-09       Impact factor: 2.545

Review 3.  Cancer in children with primary or secondary immunodeficiencies.

Authors:  B U Mueller; P A Pizzo
Journal:  J Pediatr       Date:  1995-01       Impact factor: 4.406

4.  Imaging of nonlaryngeal neuroendocrine carcinoma.

Authors:  U S Kanamalla; P P Kesava; H S McGuff
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

5.  Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

Authors:  S Adams; R Baum; T Rink; P M Schumm-Dräger; K H Usadel; G Hör
Journal:  Eur J Nucl Med       Date:  1998-01

6.  Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.

Authors:  T Belhocine; J Foidart; P Rigo; F Najjar; A Thiry; P Quatresooz; R Hustinx
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

7.  Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence.

Authors:  Russell R Broaddus; Cynthia E Herzog; M John Hicks
Journal:  Arch Pathol Lab Med       Date:  2003-09       Impact factor: 5.534

8.  Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Authors:  E Mitry; E Baudin; M Ducreux; J C Sabourin; P Rufié; T Aparicio; T Aparicio; P Lasser; D Elias; P Duvillard; M Schlumberger; P Rougier
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  8 in total
  3 in total

Review 1.  Gastric adenocarcinoma in the context of X-linked agammaglobulinemia: case report and review of the literature.

Authors:  Aidé Tamara Staines Boone; María Guadalupe Torres Martínez; Gabriela López Herrera; Julia O de Leija Portilla; Sara Elva Espinosa Padilla; Francisco J Espinosa Rosales; Saúl Oswaldo Lugo Reyes
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

Review 2.  Colorectal carcinoma in the first decade of life: a systematic review.

Authors:  René Aloisio da Costa Vieira; Maiara Silva Tramonte; Luiz Fernando Lopes
Journal:  Int J Colorectal Dis       Date:  2015-04-28       Impact factor: 2.571

3.  Gastric Adenocarcinoma in a Patient with X-Linked Agammaglobulinemia and HIV: Case Report and Review of the Literature.

Authors:  Joud Hajjar; Sana Hasan; Lisa R Forbes; Vagish Hemmige; Jordan S Orange
Journal:  Front Pediatr       Date:  2016-09-23       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.